Skip to content

Investigation of the Effects of Selective Exercise Training in Multiple Sclerosis

Investigation of the Effects of Selective Exercise Training on Muscle Architecture, Balance, Function and Fatigue in Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04853654
Enrollment
33
Registered
2021-04-21
Start date
2018-09-15
Completion date
2020-06-15
Last updated
2022-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Multiple Sclerosis

Keywords

multiple sclerosis, muscle architecture, Eccentric Exercise, Concentric Exercise

Brief summary

Selective exercise programs specific to muscle groups, with the workload to be done in line with the muscle's own structure, can enable more strength to be released with less fatigue in MS, and this increase in strength can increase balance and functional activities. to determine the effects of type training (selective exercise training), eccentric and concentric training on function, balance, fatigue and muscle architecture.

Detailed description

Recovery and enhancement of muscle function in MS is one of the main goals in physiotherapy and rehabilitation. In literature studies, it is stated that eccentric and concentric exercises are effective exercise approaches in increasing strength and reducing fatigue. However, the best exercise method is not yet clear in terms of providing better performance adaptation with less fatigue. Considering the architectural features of the lower extremity muscles, it is aimed to increase the angle of pennation with programs that include concentric strengthening of the quadriceps, gastro-soleus and gastrocnemius muscles, which are suitable muscle groups to produce large forces by design. With programs that include eccentric strengthening of the hamstring and tibialis anterior muscles that function in a wide range of motion and have high excursion ability, it is aimed to increase fiber length.

Interventions

OTHERexercise

exercise training for 8 weeks

Sponsors

Sanko University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 18-50, * With an Extended Disability Status Scale (EDSS) score of 4 or less, * No regular exercise habit * Able to walk on the treadmill, * No pregnancy, * Not receiving corticosteroid treatment in the last month, * Fampridine etc. in the last 1 month. not taking medication, * Patients who have not received Botox treatment in the last 6 months

Exclusion criteria

patients who do not agree to volunteer

Design outcomes

Primary

MeasureTime frameDescription
muscle architecture parameter 1Change from Baseline at 8th weeks and 12th weeksThe pennation angle were evaluated with Ultrasound
muscle architecture parameter 2Change from Baseline at 8th weeks and 12th weeksThe fiber length were evaluated with Ultrasound
muscle architecture parameter 3Change from Baseline at 8th weeks and 12th weeksThe muscle thickness were evaluated with Ultrasound
Muscle strengthChange from Baseline at 8th weeks and 12th weekslow extremity muscles were evaluated with hand dynamometer

Secondary

MeasureTime frameDescription
dynamic balanceChange from Baseline at 8th weeks and 12th weeks4 square step tests
Functional activities 1Change from Baseline at 8th weeks and 12th weekstimed-up go test
walking fatigueChange from Baseline at 8th weeks and 12th weeksWalking Fatigue Index
Functional activities 3Change from Baseline at 8th weeks and 12th weeks25-feet walk test
Functional activities 2Change from Baseline at 8th weeks and 12th weeks2-minute walk test
perceived fatigueChange from Baseline at 8th weeks and 12th weeksFatigue Severity Scale
physical fatigueChange from Baseline at 8th weeks and 12th weeksModified Borg Scale before and after 6-minute walking test
static balanceChange from Baseline at 8th weeks and 12th weeksSingle standing tests

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026